About AccessClosure
AccessClosure is a company based in Mountain View (United States) founded in 2002 was acquired by Cardinal Health in April 2014.. AccessClosure has raised $18.73 million across 6 funding rounds from investors including Cardinal Health, New Leaf Venture Partners and ONSET Ventures. AccessClosure operates in a competitive market with competitors including TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others.
- Headquarter Mountain View, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Access Closure, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.73 M (USD)
in 6 rounds
-
Latest Funding Round
$1.03 M (USD), Series A
Mar 14, 2013
-
Investors
Cardinal Health
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Cardinal Health
(Apr 02, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AccessClosure
AccessClosure has successfully raised a total of $18.73M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.03 million completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $1.0M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2013 | Amount | Series A - AccessClosure | Valuation |
investors |
|
| Mar, 2012 | Amount | Series A - AccessClosure | Valuation |
investors |
|
| Mar, 2010 | Amount | Series A - AccessClosure | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AccessClosure
AccessClosure has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Cardinal Health, New Leaf Venture Partners and ONSET Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life sciences are managed.
|
Founded Year | Domain | Location | |
|
Early stage VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AccessClosure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AccessClosure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Accessclosure Comparisons
Competitors of AccessClosure
AccessClosure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| domain | founded_year | HQ Location |
A device for vascular access management is developed.
|
|
| domain | founded_year | HQ Location |
AV fistula maturation and patency are supported by VasQ device.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| domain | founded_year | HQ Location |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| domain | founded_year | HQ Location |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Accessclosure
Frequently Asked Questions about AccessClosure
When was AccessClosure founded?
AccessClosure was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Where is AccessClosure located?
AccessClosure is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Is AccessClosure a funded company?
AccessClosure is a funded company, having raised a total of $18.73M across 6 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Jun 01, 2003.
What does AccessClosure do?
AccessClosure was founded in 2002 in Mountain View, United States, as a medical device company specializing in vascular access management. Products such as the Mynx delivery system were created to seal arteriotomies using water-soluble sealants that expand via absorption of fluids. These devices addressed closure needs in interventional and diagnostic cardiology procedures. The company was acquired by Cardinal Health on May 12, 2014, integrating its operations into broader healthcare solutions.
Who are the top competitors of AccessClosure?
AccessClosure's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Who are AccessClosure's investors?
AccessClosure has 6 investors. Key investors include Cardinal Health, New Leaf Venture Partners, ONSET Ventures, Three Arch Partners, and HealthCor Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.